TL;DR
This study reveals a U-shaped relationship between the triglyceride glucose index (TyG index) and mortality in middle-aged and elderly individuals with type 2 diabetes (T2D). Higher TyG index levels are associated with increased all-cause and cardiovascular disease (CVD) mortality, suggesting it could be a valuable predictive tool for this patient population.
What Problem Does This Paper Address?
Type 2 diabetes (T2D) is a growing global health concern, significantly contributing to mortality, particularly from cardiovascular disease (CVD). While insulin resistance (IR) is a key factor in T2D, traditional methods for measuring it, like the hyperinsulinemic-euglycemic clamp, are complex and costly. The triglyceride glucose index (TyG index), calculated from fasting triglycerides and glucose, has emerged as a simpler, more accessible surrogate marker for IR. While the TyG index has been linked to various metabolic conditions, its predictive power for mortality, specifically all-cause and CVD mortality, in middle-aged and elderly T2D patients remained largely unexplored. This paper aims to fill that gap by investigating this association.
Methods
The researchers utilized data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018, a nationally representative survey of the US population. They employed Cox regression models to analyze the association between the TyG index and mortality. To explore potential nonlinear relationships and identify critical thresholds, they used restricted cubic splines (RCS). The study also conducted subgroup analyses to examine how factors like age, sex, HbA1c, BMI, and smoking status influenced the TyG index's predictive power. Time-dependent receiver operating characteristic (ROC) curves were used to assess the TyG index's discriminatory ability for mortality over time.
Datasets
The primary dataset used in this study is the National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2018. This dataset includes health and nutrition information for a representative sample of the US population. Mortality data was linked through the National Death Index (NDI). No new benchmarks were introduced; the study leverages existing, publicly available data.
Key Insights and Ideas
- TyG Index as a Mortality Predictor: The study strongly suggests that the TyG index is not just a marker of insulin resistance but also a significant predictor of mortality in T2D patients, particularly in older age groups.
- U-Shaped Relationship: The most striking finding is the U-shaped association between the TyG index and mortality. This implies that both very low and very high TyG index values are associated with increased risk, suggesting a "sweet spot" for optimal outcomes.
- Thresholds Matter: The study identified specific cutoff points (8.95 for all-cause mortality and 9 for CVD mortality) where the risk significantly increases. This provides actionable thresholds for clinical monitoring.
- Subgroup Vulnerabilities: The increased risk associated with higher TyG index levels is particularly pronounced in older individuals (≥65 years), females (for all-cause mortality), males (for CVD mortality), those with higher HbA1c levels, and individuals with obesity. This highlights specific subgroups that may benefit most from closer monitoring.
Key Results
- During a median follow-up of 82 months, 883 fatalities from all causes and 265 from CVD were recorded among the 2998 T2D patients.
- The TyG index demonstrated a U-shaped relationship with both all-cause and CVD mortality.
- The critical thresholds identified were a TyG index of 8.95 for all-cause mortality and 9 for CVD mortality.
- Above these thresholds, a 1-unit increase in the TyG index was associated with a 33% increase in all-cause mortality and a 50% increase in CVD mortality, after adjusting for numerous confounding factors.
- In subgroup analyses, individuals aged ≥65, females, those with HbA1c ≥6.5%, and those with BMI ≥25 kg/m² showed a significant positive correlation between higher TyG index and all-cause mortality. For CVD mortality, similar associations were observed, with males also showing a significant correlation.
Limitations and Future Work
The authors acknowledge several limitations:
- Single Baseline Measurement: The TyG index was measured only once at baseline. This may underestimate the long-term impact of TyG index fluctuations on mortality.
- Generalizability: The study population is from the United States, and findings may not be directly generalizable to populations with different dietary patterns, living environments, or genetic backgrounds.
- Unaccounted Confounders: Despite adjusting for many relevant factors, the possibility of unmeasured confounders influencing the results remains.
Future work could involve longitudinal studies to track TyG index changes over time and their impact on mortality. Further research could also explore the mechanisms underlying the U-shaped relationship and investigate interventions to optimize TyG index levels for improved patient outcomes. The authors recommend incorporating TyG index monitoring into the routine care of diabetic patients to proactively manage their health.
Summary updated